Get the Daily Brief
Latest Biotech News
Illumina’s Acquisition of SomaLogic Advances Multiomics Strategy
Illumina announced a definitive agreement to acquire SomaLogic for up to $425 million, strategically enhancing its proteomics capabilities and bolstering its multiomics portfolio. This transaction...
Cidara Therapeutics’ Flu Prevention Biologic Shows Strong Phase 2b Results
Cidara Therapeutics’ long-acting antiviral biologic, CD-388, demonstrated robust efficacy in preventing seasonal influenza in healthy adults aged 18 to 64 in a randomized, placebo-controlled Phase...
Novo Nordisk Ends Partnership with Hims Over Compounded Obesity Drugs
Novo Nordisk terminated its marketing collaboration with Hims & Hers for the obesity drug Wegovy, accusing Hims of illegal mass compounding of the drug following the official end of a shortage...
Advanced AI Tools Aid Cancer Characterization and Treatment Precision
A multinational research collaboration including the Garvan Institute of Medical Research unveiled AAnet, an artificial intelligence tool designed to analyze cellular heterogeneity within tumors...
Breakthroughs in Gene Editing Target Mitochondrial Mutations
Scientists in the Netherlands achieved a significant milestone by utilizing mitochondrial base editing to directly correct deleterious mutations in human cells. Using a double-stranded DNA...
City of Hope Unveils Generative AI Platform for Cancer Care Enhancement
City of Hope launched HopeLLM, a proprietary generative AI platform that integrates multiple commercial and open-source models with the center’s extensive oncology data. HopeLLM automates...
New Cancer Therapeutics Emerge from Gene Regulation Research
University of Geneva researchers identified two key proteins involved in the chromatin remodeling process that regulates gene accessibility, which is crucial for controlled gene expression....
Revolution Medicines Secures $2 Billion Deal to Fund RAS Inhibitor Development
Revolution Medicines finalized a major financing agreement with Royalty Pharma, obtaining up to $2 billion in committed capital to support late-stage development and commercialization of its...
Advances in Brain Cancer Therapy Using Fusion Cytokine Technology
Researchers at Virginia Commonwealth University’s Massey Cancer Center and the Institute of Molecular Medicine designed a fusion superkine molecule combining interleukin-24S with interleukin-15,...
Revolution Medicines Secures $2 Billion Deal With Royalty Pharma To Extend RAS(ON) Cancer Drug Funding
Revolution Medicines has signed a landmark $2 billion royalty and debt financing deal with Royalty Pharma to support its RAS(ON) inhibitors, including the leading candidate daraxonrasib. This...
FDA Approves AstraZeneca and Daiichi Sankyo’s Datroway for Lung Cancer Indication
The FDA has expanded AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Datroway to include treatment for locally advanced or metastatic epidermal growth factor receptor mutated non-small...
Cidara Therapeutics’ Antiviral Shows Strong Phase IIb Results for Flu Prevention
Cidara Therapeutics announced positive Phase IIb trial results for its long-acting antiviral biologic CD-388, demonstrating substantial prevention efficacy against seasonal influenza in healthy,...
Nuvalent Advances Lung Cancer Pipeline with Promising ROS1 Drug and Plans FDA Filing
Nuvalent has revealed compelling phase 1/2 clinical results for its ROS1 inhibitor zidesamtinib, targeting ROS1-positive non-small cell lung cancer patients who failed prior therapies. The drug...
Illumina Expands Multiomics Reach with $425 Million Acquisition of SomaLogic
Illumina has entered into a definitive agreement to acquire proteomics leader SomaLogic from Standard BioTools for up to $425 million, strengthening its multiomics strategy. The purchase includes...
Novo Nordisk Ends Marketing Deal with Hims Over Obesity Drug Compounding Practices
Novo Nordisk has terminated a marketing partnership with telehealth company Hims & Hers Health after only eight weeks, alleging unlawful mass distribution of compounded versions of the obesity...
New AI Tool Deciphers Tumor Cell Diversity for Customized Cancer Treatment
A multinational research collaboration led by the Garvan Institute has introduced AAnet, an AI-based neural network designed to analyze single-cell gene expression profiles from tumors, revealing...
UK Government Unveils Strategy to Become Top Three Life Sciences Hub by 2035
The UK government has introduced a Modern Industrial Strategy focusing on boosting the life sciences sector to rank as Europe’s leader by 2030 and among the top three globally by 2035. Key...
Chromosomal Instability Biomarkers Predicting Chemotherapy Resistance in Cancer Treatment
A collaborative study led by the Spanish National Cancer Research Centre and the University of Cambridge has developed genomic biomarkers based on chromosomal instability (CIN) signatures to...
Nektar Therapeutics Surges on Positive Phase 2b Rezpeg Data in Atopic Dermatitis
Nektar Therapeutics reported encouraging Phase 2b data for rezpegaldesleukin (rezpeg), an immune-modulating agent showing statistically significant improvement in skin clearance for patients with...
Cidara's Flu Vaccine Breakthrough Boosts Stock Surge
Cidara Therapeutics reported positive top-line Phase 2b results for its long-acting antiviral biologic CD-388, demonstrating significant efficacy in preventing seasonal influenza in healthy,...